GRTX - Galera Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Galera Therapeutics's activity chart (see below) currently has 16 price targets and 26 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 30% of the time, taking 35.4 days on average.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 29-Aug-2023. First documented stock forecast 02-Dec-2019.

Best performing analysts who are covering GRTX - Galera Therapeutics:

Tazeen Ahmad Evan Seigerman Yigal Nochomovitz Raghuram Selvaraju Edward Tenthoff

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 29-Aug-2023

$80

3 years 2 months 24 days ago
(29-Aug-2023)

0/3 (0%)

$15.56 (24.15%)

Buy Since 16-Dec-2021

$60

3 years 3 months 6 days ago
(16-Aug-2023)

0/3 (0%)

$9.9 (19.76%)

Buy Since 21-Feb-2023

$100

$1200

3 years 3 months 12 days ago
(10-Aug-2023)

0/3 (0%)

$28 (38.89%)

Sell Since 16-Feb-2023

$400

3 years 9 months 6 days ago
(16-Feb-2023)

3/3 (100%)

$76 (23.46%)

39

Hold Since 11-Nov-2020

$3000

$1800

5 years 11 months 6 days ago
(16-Dec-2020)

1/2 (50%)

$808 (36.86%)

138

Show more analysts

Please expand the browser size to see the chart

What is GRTX (Galera Therapeutics) average time for price targets to be met?

On average it took 35 days for the stock forecasts to be reached, with an average price target met ratio of 30%.

Which analyst most recently updated their price target on GRTX (Galera Therapeutics)?

Yigal Nochomovitz

Which analyst has the lowest performance score on GRTX (Galera Therapeutics) with a proven track record?

EDWARD TENTHOFF

Which analyst has the most public recommendations on GRTX (Galera Therapeutics)?

Yigal Nochomovitz works at CITI and has 38 price targets and 23 ratings on GRTX

Which analyst is the currently most bullish on GRTX (Galera Therapeutics)?

Evan Seigerman with the highest potential upside of $2983.72

Which analyst is the currently most reserved on GRTX (Galera Therapeutics)?

Tazeen Ahmad with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?